Autoimmunity and epilepsy in children

Journal of Biological Research (Italy)

Volumn 86, Issue 1, 2013, Pages 9-11

  Berio, A ^a   Mangiante, G ^a   Piazzi, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

ANA; Epilepsy; Glutamic acid decarboxylase; Thyroideal antibodies; Transglutaminase

Indexed keywords

EID: 85015373469     PISSN: 18268838     EISSN: None     Source Type: Journal    
DOI: 10.4081/jbr.2013.3665     Document Type: Article

References (14)

1. Peltola J., Kulmala P., Isojarvi J., Saiz A., Latvala K., Palmio J., Savola K., Knih M., KeranenT., Garaus F.2000.Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology, 55:46-50.
2. VezzaniA., GranataT. 2005. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia, 46:1724-1743.
3. Palace J., Lang B. 2000. Epilepsy: an autoimmune disease?). Neurol. Neurosurg. Psychiatry, 69:711-714.
4. Wong-Kisiel LC., Mc Keon A., Wirrell E.C. 2012. Autoimmune encephalopathies and epilepsies in children and teenagers. Can. J. Neurol. Sci., 39:134-144.
5. Mc Knight K., Jiang Y., HartY., CakeyA., Wrol S., Blauk M., Shoenfeld Y., Vincent A., Palace J., Lang B. 2005. Serum antibodies in epilepsy and seizure associated disorders. Neurology, 65:1730-1736.
6. Hadjivassiliou M., Maki M., Sanders D.S., Williamson C.A., Gninewald RA.Woodrofe N.M., Korponay-Szabo I.R. 2006. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology, 66:373-377.
7. Verrot D., San Marco H., Dravet C., Genton P., Disdire P., Bolla G., Harle J.R., Reynaud L.Weiller P.J. 1997. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am. J. Med., 103:33-37.
8. Aarli J.A. 1993. Immunological aspects of epilepsy. Brain Dev., 15:41-50.
9. Mullen S.A., Schuffer I.E. 2009.Translation research in epilepsy genetics. Arch. Neurol., 66:21-26.
10. Giometto B., Nicolao P., Macucci M., Tavolato B., Foxon R., Bottazzo G.F. 1998.Temporal lobe epilepsy associated with GAD autoantibodies. Lancet, 352:457.
11. Saiz U., Blanco Y, Sabater L, Gonzales R, Bataller L, Casalmilcon R., Ramio-Torenta L, Garaus F. 2008. Spectrum of neurological syndromes associated with GAD antibodies. Brain, 131:2553-2563.
12. Vulliemoz S., Vanini G., TruffertA., Chizzolini C.2007.Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.J Neurol. Neurosurg. Psychiatry, 78: 187-189.
13. Hadjivassiliou M., Aeschlimann D, Grunewald R.A., Sanders D.S., Shanack B., Woodrofe N. 2010. GAD antibody-associated neurological illness and its relationship to gluten sensitivity. Acta Neurol. Scand., 123:175-180.
14. Signore A., Chianelli M., Maiuri L., Ferretti E., Barone R., Pocaccini E. Greco M., Annovazzi A., Ronga G Pozzilli P., Piccarelli A. 1997. Imaging of autoimmune phenomena in coeliac patients and associated neurological disorder. In: Epilepsy and other neurological disorder in celiac disease (G. Gobbi, F.Andermann, S. Naccarato, G. Bianchini, Eds.), John Libbey, London: 151-157.